ENVALITH
株式会社RYODEN logo

RYODEN CORPORATION

8084・Prime Market・Wholesale Trade

Official website
株式会社RYODEN logo
RYODEN CORPORATION8084

Business

RYODEN Corporation is a specialized trading company group established in 1947 as an eastern-region distributor for Mitsubishi Electric. Centered on four segments—FA Systems (FA equipment such as servos and inverters), Air Conditioning & Building Systems (air conditioning, refrigeration equipment, and building facilities), Electronics (electronic components such as memory and semiconductors), and X-Tech (Smart Agriculture, ICT, and Healthcare)—the company supplies manufacturer products to users and distributors through 19 subsidiaries in Japan and overseas. Its main customers span manufacturing industries, facility operators, data center operators, and medical institutions, and it maintains sales bases not only in Japan but also in Asia, Europe, and the Americas. Consolidated net sales for FY2026 (ending March 2026) were ¥212,772 million.

Business Model

This is a trading company-type business model in which the company enters into sales agency and distributor agreements with multiple manufacturers, including Mitsubishi Electric, procuring products and selling them to users and retailers to earn trading margins. In recent years, the company has been shifting beyond simple product sales toward higher value-added services, including system integration (with the newly established SI Business Promotion Office), energy-saving and GX solution proposals, and contract research and consulting in the Smart Agriculture business.

Company Strengths

The sales agency and dealership agreements with Mitsubishi Electric span multiple categories including equipment products, semiconductors, electronic devices, and air conditioning equipment, all with auto-renewal clauses and continuing on a long-term basis. The track record of over 70 years since the company's founding in 1947 underpins the stability of its business rights, forming a unique sales foundation that is difficult for competitors to replicate in a short period.

The company has established subsidiaries across Asia (Thailand, Vietnam, Singapore, Taiwan, China, Malaysia), Europe (Germany), and the Americas (the United States, Mexico), while operating a three-branch structure domestically covering Eastern Japan, Western Japan, and Central Japan. In FY2026 (ending March 2026), Electronics segment assets reached ¥74,246 million, with the global sales infrastructure underpinning the earnings base.

The X-Tech segment recorded net sales of ¥8,496 million and operating profit of ¥122 million in FY2026 (ending March 2026), achieving full-year profitability. In the Smart Agriculture field, the company maintains the top market share in plant factory vegetable sales, while also expanding its business domain into contract research, consulting, and test plants leveraging photosynthesis optimization technology.

ENVALITH's Perspective

Electronics, which accounts for approximately 55% of net sales, continues to see declining revenue in FY2026 (ending March 2026) at ¥117,507 million (down 7.1% year on year). The instability in the Chinese market for industrial equipment and prolonged inventory adjustments, along with the slowdown in BEVs for automotive applications, are weighing on results, while external factors such as US tariff policy and geopolitical risks remain as downside factors. AI server-related demand for data centers is strong, but a full-scale recovery in industrial equipment and automotive is essential to lift overall performance, and there is high uncertainty regarding achievement of the FY2027 (ending March 2027) forecast (net sales of ¥237,000 million, up 11.4% year on year).

X-Tech achieved full-year profitability in FY2026 (ending March 2026) with operating profit of ¥122 million, but its contribution to the company as a whole remains limited, with net sales of ¥8,496 million and segment assets of ¥4,875 million. The utilization of power-saving technology in the Smart Agriculture (Plant Factory Systems) field and the expansion of contracted research are commendable, but in the Healthcare (Medical Facilities) field, a slowdown in capital investment by medical institutions is a headwind. Progress on the mid- to long-term plan, which positions FY2026 as a "monetization and expansion phase," will be an important factor in assessing corporate value.

Profit attributable to owners of parent for FY2026 (ending March 2026) increased to ¥5,275 million (up 12.2% year on year), but operating profit decreased to ¥5,244 million (down 4.3% year on year), indicating a decline in core business profitability. The main driver of the profit increase was extraordinary gains totaling ¥1,754 million (up ¥1,253 million year on year), consisting of gain on sale of shares of affiliated companies of ¥1,019 million and gain on sale of investment securities of ¥734 million, while ordinary profit also decreased to ¥5,767 million (down 4.0% year on year). Selling, general and administrative expenses expanded to ¥24,511 million (up 11.1% year on year) due to investments in human capital and strategy, and the recovery of core business profitability will be an important point to confirm in FY2027 (ending March 2027).

Growth Strategy

Transformation into a business-creating company and transition to a monetization phase under "ONE RYODEN Growth 2029 | 2034"

As the first year of the medium- to long-term plan starting in FY2025 (fiscal year ended March 2026), the company continues human capital investment and strategic investment across all segments. FY2026 (ending March 2026) [Translator note: see clarification below] is positioned as the transition year toward a "monetization and expansion phase," aiming to generate returns on growth investments in DX, human capital, business development, alliances, and other areas. Capital efficiency management with an emphasis on improving ROIC is being thoroughly implemented.

The company has newly established the "SI Business Promotion Office," which proposes company-wide, cross-divisional solutions leveraging the strengths of each business division. The office aims to scale the innovation strategy and establish a medium- to long-term revenue base. Through the expansion of high-value-added businesses, the company seeks to improve its gross profit margin.

The company aims to maintain its top share in plant factory vegetable sales in the Smart Agriculture (Plant Factory Systems) field, while expanding contracted research, consulting, and test plant orders leveraging power-saving technology. Full-year profitability (operating profit of ¥122 million) was achieved in FY2026 (ending March 2026). The company also continues to nurture sales of FlaRevo in the ICT field and electronic medical record-related equipment in the Healthcare (Medical Facilities) field.

From the beginning of FY2026 (ending March 2026), the company changed its depreciation method for tangible fixed assets from the declining-balance method to the straight-line method. This aims to rationalize cost allocation in line with the policy of expanding the subscription business and other sources of stable, long-term income. As a result of this change, depreciation expense for the current period decreased by ¥77 million, boosting operating profit by the same amount.

The company introduced progressive dividends, with an annual dividend of ¥138 for FY2026 (ending March 2026) (dividend payout ratio of 56.4%) and a forecast of ¥150 for FY2027 (ending March 2027). The market-value-based equity ratio rose to 45.8% (from 38.1% in the previous period), and the evaluation in the stock market has also improved. The company aims for continuous improvement in capital efficiency through the setting of management indicators that emphasize ROIC improvement.

Last updated: July 19, 2026